Heterogeneity of the inhibitory effects of IL-4 in two novel B lineage acute lymphoblastic leukemia cell lines

Leuk Res. 1997 Nov-Dec;21(11-12):1037-46. doi: 10.1016/s0145-2126(97)00099-4.

Abstract

The present study describes two novel cell lines, DUNATIS and SILVANUS, established from B lineage acute lymphoblastic leukemia patients. Respectively, DUNATIS and SILVANUS display an early pre-B cell and a pre-B cell phenotype. Spontaneous DNA replication of both cell lines was strongly inhibited by IL-4. This effect was directly mediated by IL-4 and exerted through the CD124 IL-4 receptor chain. Notably, IL-4 was associated with rapid cell death and reduction of cellularity in DUNATIS, whereas these parameters were considerably less pronounced and only observed after longer-term exposure of the SILVANUS cells to IL-4. In addition to these differences, although both cell lines expressed FES oncoprotein, a 100 kDa protein associated with FES was strikingly found to be tyrosine-phosphorylated in response to IL-4 exclusively in DUNATIS cells. These data demonstrate that IL-4 displays heterogenous effects on leukemic B cell precursors responsive to inhibition of DNA synthesis via IL-4 mediated engagement of the CD124 receptor chain. The present findings may be of use for appreciation of the effects of IL-4 in B lineage ALL, and the novel cell lines could represent a model for further identification of target molecules in IL-4 signalling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Burkitt Lymphoma / drug therapy*
  • Burkitt Lymphoma / metabolism
  • Burkitt Lymphoma / pathology*
  • Cell Division / drug effects
  • Cell Survival / drug effects
  • DNA Replication / drug effects
  • DNA, Neoplasm / biosynthesis
  • DNA, Neoplasm / drug effects
  • Female
  • Humans
  • Interleukin-4 / pharmacology*
  • Male
  • Neoplasm Proteins / metabolism
  • Phenotype
  • Phosphorylation / drug effects
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / metabolism
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Protein-Tyrosine Kinases*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-fes
  • Tumor Cells, Cultured / drug effects

Substances

  • DNA, Neoplasm
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • Interleukin-4
  • Protein-Tyrosine Kinases
  • FES protein, human
  • Proto-Oncogene Proteins c-fes